These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5669169)

  • 21. [Antihypertensive effect of an imidazole derivative in a group of elderly patients].
    Piliego N; Marinazzo A; De Donno G; Pezzuto A
    Clin Ter; 1970 Nov; 55(3):219-25. PubMed ID: 5516886
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension].
    Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh
    Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypotensive treatment with an imidazoline derivative].
    Björk-von Bahr S
    Lakartidningen; 1969 Sep; 66(37):3701-4. PubMed ID: 5378942
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on the effect of dichlorphenylaminoimidazoline (Haemiton) in arterial hypertension].
    Thiel H; Mitschke H
    Dtsch Gesundheitsw; 1970 Nov; 25(45):2109-15. PubMed ID: 5487971
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 27. [Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
    Gurevich MA
    Klin Med (Mosk); 2002; 80(9):9-13. PubMed ID: 12416217
    [No Abstract]   [Full Text] [Related]  

  • 28. [ECG studies following oral administration of a new antihypertensive substance (Catapresan)].
    Strössenreuther H
    Med Monatsschr; 1966 Dec; 20(12):565-6. PubMed ID: 5980274
    [No Abstract]   [Full Text] [Related]  

  • 29. [1st results with a new antihypertensive agent; or imidazoline hydrochloride (ST 155)].
    Faerchtein I; Francisco Roque A; Kastansky I; Kac LB
    Hospital (Rio J); 1969 May; 75(5):1691-700. PubMed ID: 5306498
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension].
    Kobalava ZhD; Tolkacheva VV; Ignat'ev IV; Glezer MG; Kuzin AI; Karpov IuA; Konradi AO; Zheleznykh EA
    Ter Arkh; 2005; 77(1):46-51. PubMed ID: 15759454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of phisiotens for the treatment of arterial hypertension in elderly patients].
    Ostroumova OD; Mamaev VI; Bagramova IuA; Rybkina TE; Kuz'michev IA
    Ter Arkh; 2001; 73(9):17-22. PubMed ID: 11642073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative trial of timolol and flutonidin as antihypertensive agents.
    Salvadeo A; Segagni S; Villa G; Galli F; Piazza W; Bovio G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):78-84. PubMed ID: 7037661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clonidine in migraine therapy].
    Tedeschi G
    Acta Neurochir (Wien); 1971; 24(5):633-42. PubMed ID: 5160995
    [No Abstract]   [Full Text] [Related]  

  • 35. [Variability of arterial pressure in arterial hypertension and effects of antihypertensive therapy].
    Martynov AI; Ostroumova OD; Mamaev VI; Rybkina TE; Novinskiĭ AA; Mel'nikov OA; Akimov VN
    Klin Med (Mosk); 2002; 80(6):4-7. PubMed ID: 12138801
    [No Abstract]   [Full Text] [Related]  

  • 36. [Moxonidine. A new antihypertensive agent of central action].
    Leães CG; Rosito GA
    Arq Bras Cardiol; 1998 Jun; 70(6):443-8. PubMed ID: 9713089
    [No Abstract]   [Full Text] [Related]  

  • 37. Abrupt withdrawal of the antihypertensive agent tiamenidine after 12-months' treatment.
    Gerlis LS; Wright N
    Pharmatherapeutica; 1980; 2(6):408-11. PubMed ID: 7001495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
    Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
    Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New angiotensin-II blocker.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
    [No Abstract]   [Full Text] [Related]  

  • 40. [Obesity and hypertension. A dangerous liaison].
    MMW Fortschr Med; 2002 Oct; 144(43):57. PubMed ID: 12534023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.